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In tro ductio n  
  
The most common disorder treated by pediatric neurosurgeons is 
hydrocephalus.  A recent review of inpatient data in the United States found 
that $1–2 billion is spent each year on the management of hydrocephalus.13  
This paper will review the indications for treatment of hydrocephalus, the 
selection of a procedure and equipment, implantation techniques, follow-up, 
and complications.  
 
In dicatio n s  fo r Treatm e n t 
The decision to implant a ventriculoperitoneal shunt in a child with 
ventriculomegaly should not be taken lightly.  Once a shunt has been im-
planted, it is very difficult to determine that it is no longer necessary, and 
therefore the initial decision is very important.  Sometimes the need is obvious, 
such as a baby who presents with irritability, vomiting, a full fontanelle, 
splayed sutures, and increasing head circumference.  Similarly, older children 
with headaches, vomiting, and papilledema clearly require intervention.  At the 
other end of the spectrum are children with moderately enlarged ventricles, 
normal development, and no progression in head size or ventricle size on 
imaging.  Although the ventricles may be bigger than average in these children, 
a shunt should not be implanted unless their symptoms progress. 
 
Ventriculoperitoneal Shunts in Children: Indications, Equipment  & Techniques 
 
The essential factor in the decision to treat hydrocephalus is a progressive 
change over time.  This may be progression of ventricle size on imaging, head 
size, or neurologic function.  In a baby, loss of neurologic function may be 
manifested as lack of normal developmental progress.  A decision to implant a 
shunt on a single visit is rare except in the extreme situation, and observation 
over time, looking for progressive change, is the most useful test.  
 
In rare situations, intracranial pressure monitoring may be helpful.  Fouyas et al. 
monitored 18 previously unshunted patients in whom the diagnosis of 
hydrocephalus was suspected but uncertain.3  Repeated examinations and 
imaging had failed to demonstrate a clear need for a shunt.  In 9 of the 18 
patients, the intracranial pressure was elevated on monitoring, and all of these 9 
improved symptomatically with shunt placement. 
 
The decision to treat hydrocephalus can be particularly difficult in the 
premature child after intraventricular hemorrhage.  Typically, these children 
have been treated with an implanted reservoir, which is tapped periodically to 
maintain a reasonable head circumference.  As the child matures towards term, 
the taps are weaned and the child is observed for apnea, bradycardia, 
progressive head enlargement, ventriculomegaly, and feeding difficulties.  The 
likelihood of converting a ventricular access device or subgaleal shunt to a 
permanent shunt has recently been reviewed and found to be approximately 50 - 
70% for patients with Grade III and IV intraventricular hemorrhage.14 
 
Children with posterior fossa tumors have a significant incidence of 
hydrocephalus.  In the past, preoperative shunting had been common practice, 
but this is no longer the case, since a significant proportion of patients remain 
shunt free after tumor removal.  A predictive score, which can be used to 
identify patients at high risk of hydrocephalus, has been developed and 
validated for this population.11 
 
Shun t Place m e n t v s . Third Ve n tricu lo s to m y 
A subset of children with hydrocephalus are candidates for third 
ventriculostomy rather than shunt placement.  The ideal candidates are older 
children with obstructive hydrocephalus at the level of the aqueduct.  The 
failure rates of third ventriculostomy and shunts have been compared, and the 
complications associated with third ventriculostomy have recently been 
reviewed.2  Candidates for third ventriculostomy are usually older than those 
who are treated with shunts, and the most common causes of hydrocephalus 
treated by third ventriculostomy are aqueduct stenosis and tumor.  The success 
rate of third ventriculostomy is 65% at 1 year and 52% at 2 years, almost 
identical to that of initial ventriculoperitoneal shunts.  Children of a younger 
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age, particularly neonates and infants, are thought to have significantly higher 
failure rates with third ventriculostomy.2 
 
Se le ctio n  o f Shun t Equipm e n t 
 
Ventricular and peritoneal catheters that are impregnated with antibiotics are 
now available.  The intent is to reduce the incidence of shunt infection, but the 
data are mixed, with some studies showing favorable results.1,4,12   Others being 
equivocal.5  Among these studies, the single randomized trial appeared to show 
a reduced infection rate, but HIV-positive patients, patients with a recent shunt 
infection, and adults were included in the patient population.4  In addition, the 
infection rate in the control group was high (17%).  As yet, a large, well-
controlled, randomized trial demonstrating efficacy has not been done.  
Anecdotal experience has suggested that antibiotic-impregnated catheters may 
make a shunt infection more difficult to diagnose.  Hydrophobic catheters 
(Bactiseal) are also available but have not been shown to reduce infection rates 
or decrease tissue adherence. 
 
Many valves are available on the market; they can be categorized in terms of 
their flow characteristics and whether or not they are adjustable.  The flow 
characteristics of differential pressure valves, Delta valves, and Sigma valves 
were compared in a randomized trial (Fig. 1) and no difference in overall shunt 
survival was found.6  A randomized trial comparing the adjustable Codman 
valve also did not show an advantage.9  A non-randomized cohort study of the 
Strata valve showed similar shunt survival to other valves on the market (Fig.  
2).8 
 
In the absence of strong evidence favoring one valve over another, the author’s 
preference is as follows: 
 
Figure 1: Time to first failure after initial shunt placement in children 
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  For children with newly diagnosed hydrocephalus, a medium pressure 
differential valve is implanted. 
  For older children with large ventricles who appear to be at high risk of 
acute overdrainage with subdural hematoma, an Orbis Sigma valve is 
implanted. 
  Adjustable valves are not used unless they are part of a study protocol. 
 
Some pediatric neurosurgeons use adjustable valves in newly diagnosed 
hydrocephalus.  Then, after the intracranial pressure has been relieved and the 
wound has healed, they increase the setting to try to prevent the development of 
small ventricles.  The efficacy of this approach has not yet been demonstrated. 
 
Im plan tatio n  Te chn ique  
The patient is positioned supine with the head turned contralateral to the site of 
ventricular catheter insertion.  To prevent infection, prophylactic antibiotics are 
used, and the surgeon wears double gloves for the procedure.  Cefazolin is 
administered before the first incision and once postoperatively.  Hair is clipped 
along the incision site, which is prepped with chlorhexidine.  Either a coronal or 
a posterior parietal entry site can be chosen, and the choice does not appear to 
affect the long-term survival of the shunt.  The coronal site allows better 
visualization of the foramen of Monroe should the use of endoscopy be 
necessary at a later date.  Endoscopic insertion of the ventricular catheter at the 
time of initial shunt placement was not shown to be advantageous, but shunt 
survival appears to be improved if the tip of the ventricular catheter is away 
from the choroid plexus.7 
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For a coronal entry site, a semicircular incision is made at the lateral margin of 
the anterior fontanelle (in the mid-pupillary line), a second incision is made 
behind the ear, and a third in the side of the abdomen.  The valve and peritoneal 
tubing are passed subcutaneously between these wounds before the ventricular 
catheter is placed.  The ventricular catheter is then implanted, and some of the 
fluid is allowed to drain so that any debris or blood is drained off and does not 
enter the system where it might plug the valve.  Fluid should be seen flowing 
from the peritoneal end of the catheter without aspiration before it is implanted 
in the peritoneum.  Either an open minilaparotomy technique or implantation 
with an abdominal trocar is used.  The use of a trocar should be avoided in 
children who have undergone multiple previous operations or have abdominal 
scars. 
 
Once the system is in place, vancomycin 10 mg and gentamicin 4 mg are 
injected into the reservoir using a butterfly needle.10 
 
Fo llo w -Up 
The patient is seen in follow-up one month after surgery to evaluate wound 
healing and clinical symptoms.  Computed tomography scanning is performed 
at 3 and 12 months after surgery.  Data from the Shunt Design Trial indicate the 
ventricle size will decrease by 3 months but will decrease further until 12 
months after surgery and then stabilize (Fig. 3).   
 
For that reason, both images are important. The 3-month image is necessary 
because failure is so common in the first year after shunt placement, and the 1-
year image is necessary as the appropriate baseline for subsequent follow-up.  
Patients and their families are instructed with regard to symptoms of 
malfunction and infection.  Patients who present with fever in follow-up are 
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investigated for shunt infection if they present within 6 months of an operation.  
In a child who presents more than 6 months after a surgical procedure with a 
fever, other sources of infection should be evaluated before a shunt tap is 
warranted.  
 
Co m plicatio n s  
Shunt failure is common in the first year after implantation, with the shunt 
failing in a third of patients for noninfectious reasons and 5 - 10% of patients 
suffering shunt infection.  The most common cause of failure is shunt obstruc-
tion, which can, of course, present at any time and is most commonly due to 
ventricular catheter blockage.  Obstruction of a valve may occur, often quite 
soon after shunt implantation because of obstruction by cellular debris or blood 
getting into the valve at the time of implantation.  The vast majority of 
infections occur within 6 months.  Acute overdrainage resulting in subdural 
hematoma also usually occurs early (in the first few months).  Shunt migration 
also occurs very early, but disconnection or fracture of the peritoneal tubing is a 
very late complication, after the outer surface has become calcified, rough, and 
adherent. 
 
Complications related to intracranial catheter placement include hemorrhage 
and neurologic injury with misplacement of the catheter into eloquent areas of 
brain parenchyma.  Fortunately, these are rare.  At the distal end, abdominal 
perforation can occur either at the time of implantation or in a chronic fashion 
with erosion of the peritoneal tubing through the viscera wall.  Patients with 
abdominal pseudocysts, presumably due to low-grade infection with 
Staphylococcus epidermidis or Propionibacterium acnes, may present with an 
abdominal mass and symptoms of shunt malfunction. 
 
Co n clus io n  
 
The management of hydrocephalus is the most common task of the pediatric 
neurosurgeon.  It is therefore important to become familiar with its presenta-
tion, management, and complications.  Further investigation into the indications 
for shunting, the prevention of infection, and optimal shunt hardware are 
needed. 
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